NEW
Stock Screener with Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
Last Price$238.0(1.1%)
Market Cap$30.1B
Last Earnings date
Sep'24
Q3 2024
($0.87)
18.5% beat
$500.9M
12.0% beat
Next quarter EPS Estimate
($0.62)
(43.6%)YoY
ALNY Earnings and Expectations
Revenue
Crunching data... Almost there!
ALNY EPS (Earnings Per Share)
Crunching data... Almost there!
ALNY Historical Revenue & EPS and Expectations
Crunching data... Almost there!
ALNY Earnings History
Crunching data... Almost there!
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
Crunching data... Almost there!
Competing with ALNY Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Investing armour 2024
50+ visuals to equip yourself with investing wisdom.
Sign up to receive it for FREE
FAQ
1. When was Alnylam Pharmaceuticals, Inc.'s last earnings date?
Alnylam Pharmaceuticals, Inc.'s last earnings date was Sep'24 (Q3 2024).
2. What is Alnylam Pharmaceuticals, Inc.'s EPS, and was there a surprise?
Alnylam Pharmaceuticals, Inc.'s EPS was ($0.87), with a 18.5% beat.
3. What is Alnylam Pharmaceuticals, Inc.'s revenue, and was there a surprise?
Alnylam Pharmaceuticals, Inc.'s revenue was $500.9M, with a 12.0% beat.
4. What is Alnylam Pharmaceuticals, Inc.'s next quarter EPS estimate?
Alnylam Pharmaceuticals, Inc.'s next quarter EPS estimate is ($0.62), with an expected (43.6%) YoY growth.